We are live on
!
Find out more
GCM
Garland Capital Management Portfolio holdings
AUM
$7.27M
Turnover
27.59%
1-Year Est. Return
14.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.03%
1 Year Est. Return
+14.85%
3 Year Est. Return
+55.71%
5 Year Est. Return
+87%
10 Year Est. Return
+180.2%
AUM
$118M
AUM Growth
-$20.6M
(-15%)
Cap. Flow
-$22.3M
Cap. Flow
% of AUM
-18.83%
Top 10 Holdings %
Top 10 Hldgs %
36.9%
Holding
43
New
–
Increased
–
Reduced
35
Closed
8
Avg Time Held
0.3
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.2
years
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Healthpeak Properties
DOC
|
+$3.61M |
| 2 |
Travelers Companies
TRV
|
+$3.23M |
| 3 |
PROLOGIS
PLD
|
+$2.86M |
| 4 |
Bank of New York Mellon
BNY
|
+$2.49M |
| 5 |
TotalEnergies
TTE
|
+$2.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.19% |
| 2 | Healthcare | 16.04% |
| 3 | Real Estate | 14.96% |
| 4 | Consumer Staples | 12.09% |
| 5 | Technology | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Illinois Tool Works
ITW
$77.3B
| $5.17M | 4.37% |
67,760
-400
| -0.6% | -$29.2K |
2013 Q2
1 quarter
|
|
2
RTX Corp
RTX
$260B
| $4.73M | 4% |
69,654
-477
| -0.7% | -$31.2K |
2013 Q2
1 quarter
|
|
|
STJ
3
DELISTED
St Jude Medical
STJ
| $4.7M | 3.97% |
87,550
-550
| -0.6% | -$28.3K |
2013 Q2
1 quarter
|
|
4
Microsoft
MSFT
$3.91T
| $4.56M | 3.86% |
136,980
-600
| -0.4% | -$19.7K |
2013 Q2
1 quarter
|
|
5
3M
MMM
$84.5B
| $4.54M | 3.85% |
45,508
-119
| -0.3% | -$11.6K |
2013 Q2
1 quarter
|
|
6
Johnson & Johnson
JNJ
$616B
| $4.17M | 3.53% |
48,130
-500
| -1% | -$44.9K |
2013 Q2
1 quarter
|
|
7
IBM
IBM
$218B
| $4.16M | 3.52% |
23,477
-105
| -0.4% | -$19.1K |
2013 Q2
1 quarter
|
|
8
Buckle
BKE
$2.39B
| $3.92M | 3.32% |
74,298
-513
| -0.7% | -$27.1K |
2013 Q2
1 quarter
|
|
9
Unilever
UL
$142B
| $3.84M | 3.25% |
88,467
-444
| -0.5% | -$20.1K |
2013 Q2
1 quarter
|
|
10
Walmart Inc
WMT
$942B
| $3.81M | 3.22% |
154,425
-1,350
| -0.9% | -$34K |
2013 Q2
1 quarter
|
|
11
DELISTED
Du Pont De Nemours E I
DD
| $3.79M | 3.21% |
68,129
-421
| -0.6% | -$23K |
2013 Q2
1 quarter
|
|
12
Chevron
CVX
$440B
| $3.79M | 3.2% |
31,160
-100
| -0.3% | -$12.3K |
2013 Q2
1 quarter
|
|
13
Pfizer
PFE
$168B
| $3.72M | 3.15% |
136,406
-1,054
| -0.8% | -$28.7K |
2013 Q2
1 quarter
|
|
14
Prudential Financial
PRU
$40B
| $3.65M | 3.09% |
46,850
-350
| -0.7% | -$27.5K |
2013 Q2
1 quarter
|
|
15
Procter & Gamble
PG
$368B
| $3.57M | 3.02% |
47,225
-400
| -0.8% | -$31.8K |
2013 Q2
1 quarter
|
|
16
Welltower
WELL
$169B
| $3.47M | 2.94% |
55,675
-350
| -0.6% | -$22.3K |
2013 Q2
1 quarter
|
|
17
Novartis
NVS
$286B
| $3.45M | 2.92% |
50,220
-335
| -0.7% | -$22.2K |
2013 Q2
1 quarter
|
|
|
TIF
18
DELISTED
Tiffany & Co.
TIF
| $3.43M | 2.91% |
44,800
-400
| -0.9% | -$31.5K |
2013 Q2
1 quarter
|
|
19
JPMorgan Chase
JPM
$900B
| $3.37M | 2.85% |
65,150
-450
| -0.7% | -$24.1K |
2013 Q2
1 quarter
|
|
20
United Parcel Service
UPS
$82.4B
| $3.19M | 2.7% |
34,925
-100
| -0.3% | -$8.79K |
2013 Q2
1 quarter
|
|
21
GE Aerospace
GE
$327B
| $3.16M | 2.67% |
27,605
-208
| -0.7% | -$23.9K |
2013 Q2
1 quarter
|
|
22
Tapestry
TPR
$23.8B
| $3.14M | 2.66% |
57,550
-350
| -0.6% | -$19.3K |
2013 Q2
1 quarter
|
|
23
PepsiCo
PEP
$179B
| $3.06M | 2.59% |
38,500
-200
| -0.5% | -$16.4K |
2013 Q2
1 quarter
|
|
24
Baxter International
BAX
$13B
| $2.92M | 2.47% |
81,740
-553
| -0.7% | -$21.5K |
2013 Q2
1 quarter
|
|
25
ExxonMobil
XOM
$733B
| $2.88M | 2.43% |
33,430
-300
| -0.9% | -$27K |
2013 Q2
1 quarter
|
|
Similar funds
HL
IIGPLP
LSC
CG
LFA
SGIHM
TAC
YU
Garland Capital Management's Q3 2013 Portfolio in Review
As of Q3 2013, Garland Capital Management held 43 positions worth $118M, down 15% from $139M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Garland Capital Management withdrew a net $22.3M in Q3 2013, closing 8 positions and reducing 35 holdings. Its most notable exit was Healthpeak Properties, an estimated $3.61M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 19% a quarter earlier, followed by Healthcare and Real Estate.
- Garland Capital Management's biggest Q3 2013 reduction was Johnson & Johnson, cutting an estimated $44.9K.
- Garland Capital Management fully exited Healthpeak Properties in Q3 2013, selling an estimated $3.61M.
- Garland Capital Management's ten largest holdings make up 37% of its $118M portfolio in Q3 2013.
- Garland Capital Management opened 0 new positions and closed 8 in Q3 2013.
- Garland Capital Management's portfolio value fell 15% quarter-over-quarter to $118M.
Based on Garland Capital Management's 13F filing for Q3 2013, filed 6 Nov 2013.